D L Carlson Investment Group Inc Glaukos Corp Transaction History

D L Carlson Investment Group Inc

  • $541 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 11, 2018
SELL
$26.05 - $34.5 $594,851 - $787,807
-22,835 Closed
0 $0
Q4 2017

Feb 09, 2018
SELL
$24.5 - $36.01 $430,832 - $633,235
-17,585 Reduced 43.51%
22,835 $586,000
Q3 2017

Nov 13, 2017
BUY
$31.26 - $42.03 $1.26 Million - $1.7 Million
40,420
40,420 $1.33 Million

Others Institutions Holding GKOS

# of Institutions
346
Shares Held
46.7M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.44B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track D L Carlson Investment Group Inc Portfolio

Follow D L Carlson Investment Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D L Carlson Investment Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on D L Carlson Investment Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email